AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9448656
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR (100‐300 mg/day)
Trial: 11910265
Drug: Sertraline (50‐200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50‐200 mg/day)
Trial: 7939468
Drug: LHRH agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LHRH agonist (Zoladex)
Trial: 3374415
Drug: Continuing medical
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuing medical education (CME) in cardiovascular and cancer medicine
Trial: 29331663
Drug: Mitomycin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitomycin (40 mg)
Trial: 31720933
Drug: Oxaliplatin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxaliplatin (200 mg/m2)
Trial: 31666152
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (0.2 mg) IN SCOP
Trial: 31666152
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (0.4 mg) IN SCOP
Trial: 21742071
Drug: ronacaleret 200
RxNorm normalized name: Ronacaleret
DrugBank: Ronacaleret (DB05255)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ronacaleret 200 mg twice daily
Trial: 21742071
Drug: ronacaleret 400
RxNorm normalized name: Ronacaleret
DrugBank: Ronacaleret (DB05255)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ronacaleret 400 mg once daily
Trial: 19445553
Drug: Oxycodone 5
RxNorm normalized name: oxycodone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 5 mg and paracetamol 325 mg up to 8 hourly for >/= 6 weeks (group A)
Trial: 19445553
Drug: Oxycodone 5
RxNorm normalized name: oxycodone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 5 mg and paracetamol 325 mg up to 8 hourly for >/= 6 weeks (group B)
Trial: 19445553
Drug: Oxycodone/paracetamol therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone/paracetamol therapy (group B)
Trial: 19445553
Drug: Oxycodone/paracetamol therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone/paracetamol therapy (both groups)
Trial: 16778460
Drug: None of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: None of the agents
Trial: 11787984
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg iron daily (enriched with Zn, Cu, Se, vitamin B12, and folate)
Trial: 11787984
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (15 mg iron)
Trial: 3291161
Drug: RT following
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT following chemotherapy
Trial: 3291161
Drug: RT following
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT following low dose concurrent irradiation with chemotherapy (LDC‐RT)
Trial: 3291161
Drug: RT concurrently
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT concurrently used with chemotherapy
Trial: 27765707
Drug: Early physical
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early physical therapy (initiated within 28 days of the index visit)
Trial: 27765707
Drug: No early
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No early physical therapy
Trial: 25487817
Drug: DAPT with
RxNorm normalized name: DAPT
DrugBank: Diaminopropanol tetraacetic acid (DB12362)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAPT with cilostazol and aspirin or clopidogrel
Trial: 25487817
Drug: Aspirin or
RxNorm normalized name: aspirin Oral Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin or clopidogrel monotherapy
Trial: 25487817
Drug: DAPT with
RxNorm normalized name: DAPT
DrugBank: Diaminopropanol tetraacetic acid (DB12362)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAPT with cilostazol and aspirin
Trial: 22073891
Drug: Warm acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm acupuncture combined with intra-articular injection of sodium hyaluronate
Trial: 22073891
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (intra-articular injection of sodium hyaluronate only)
Trial: 15285333
Drug: Daonil tablets
RxNorm normalized name: Daonil
DrugBank: Glyburide (DB01016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daonil tablets (Hoechst)
Trial: 12738722
Drug: Erythropoietin (r‐HuEpo)
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (r‐HuEpo) 40,000 IU s.c. once weekly
Trial: 10957752
Drug: Estrogen alone
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen alone or in combination with progestogens
Trial: 1308305
Drug: Midazolam (0.10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.10 mg/kg)
Trial: 3497885
Drug: Co-trimoxazole suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole suspension alone
Trial: 3497885
Drug: Co-trimoxazole suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole suspension with pectin-kaolin
Trial: 30377210
Drug: Rose geranium
RxNorm normalized name: ALCOHOL 62 mL in 100 mL TOPICAL SPRAY [All Good Rose Geranium Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rose geranium nasal spray
Trial: 29208831
Drug: Trypan blue
RxNorm normalized name: Trypan Blue
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trypan blue dye (0.06%) irrigation in the capsular bag, 0.2 ml injected after cortical cleanup under air.
Trial: 29208831
Drug: Balanced salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced salt solution, 0.2 ml injected in a similar manner as the dye group.
Trial: 29208831
Drug: Balanced salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced salt solution.
Trial: 22018129
Drug: Gynol II
RxNorm normalized name: Gynol II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gynol II vaginal gel
Trial: 22018129
Drug: Hydroxyethyl cellulose
RxNorm normalized name: Hydroxyethyl Cellulose
DrugBank: Hydroxyethyl cellulose (DB11602)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethyl cellulose gel (HEC)
Trial: 22018129
Drug: No gel
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No gel exposure
Trial: 12588271
Drug: Digoxin (SDC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (SDC 0.5-0.8 ng/mL, n = 572)
Trial: 12588271
Drug: Digoxin (SDC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (SDC 0.9-1.1 ng/mL, n = 322)
Trial: 12588271
Drug: Digoxin (SDC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (SDC >=1.2 ng/mL, n = 277)
Trial: 9398695
Drug: Oral 17
RxNorm normalized name: polyoxypropylene (17)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 17 beta‐estradiol (2 mg/day)
Trial: 31073087
Drug: Domiciliary oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domiciliary oxygen therapy (DOXT)
Trial: 16729780
Drug: Roflumilast (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roflumilast (all doses)
Trial: 15585624
Drug: Interleukin-2 (IL-2)
RxNorm normalized name: Fusion protein comprised of a circularly-permuted interleukin-2 (IL-2) with the extracellular domain of IL-2 receptor alpha
DrugBank: Human interleukin-2 (DB14865)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-2 (IL-2) based immunotherapy
Trial: 11322841
Drug: Immediate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate treatment (individualized stress management)
Trial: 11322841
Drug: Combined sample
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined sample (after treatment for wait list control)
Trial: 9032045
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (80 parts per million)
Trial: 8302530
Drug: 40 mg/day
RxNorm normalized name: cabozantinib s-malate 140 mg/day (80 mg x 1-20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/day of lovastatin
Trial: 3558996
Drug: Azatadine (topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azatadine (topical tricyclic antihistamine)
Trial: 27602906
Drug: Valproic acid
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproic acid (VPA) 120 mg/kg over 1 hour
Trial: 21495269
Drug: Adalat 10
RxNorm normalized name: Adalat 10mg Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalat 10 capsule
Trial: 22850606
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg orally after radiotracer injection
Trial: 19960970
Drug: Ginsenosides (GS)
RxNorm normalized name: ginsenoside
DrugBank: Ginsenosides (DB14152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginsenosides (GS) Capsule (50 mg) twice daily
Trial: 19960970
Drug: Placebo capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsule of equal dosage
Trial: 11585356
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of retinyl palmitate
Trial: 11585356
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of retinyl palmitate plus 2 microg of 1,25(OH)2D3
Trial: 9572322
Drug: Misoprostol 200
RxNorm normalized name: MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol 200 microg four times daily
Trial: 7837406
Drug: DFK group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DFK group (total intravenous anesthesia with droperidol, fentanyl and ketamine)
Trial: 27018027
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (Ibuprofen + amoxicillin, clavulanic acid)
Trial: 27018027
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (Ibuprofen only)
Trial: 20575711
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy suspension for 1 or 2 months before the next screening mammogram.
Trial: 19106467
Drug: Gradia (G)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gradia (G)
Trial: 8637789
Drug: Biweekly schedule
RxNorm normalized name: Biweekly Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biweekly schedule of 1.2 million U intramuscular benzathine penicillin G (BPG)
Trial: 8637789
Drug: 4-week schedule
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week schedule of 1.2 million U intramuscular benzathine penicillin G (BPG)
Trial: 31125274
Drug: Brigatinib treatment
RxNorm normalized name: Brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Brigatinib treatment
Trial: 16272960
Drug: GW320659 (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GW320659 (15 mg/day)
Trial: 10197321
Drug: Coumarin 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coumarin 90 mg/day (Group A)
Trial: 10197321
Drug: Coumarin 135
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coumarin 135 mg/day (Group B)
Trial: 8657434
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 60 mg/ml
Trial: 8657434
Drug: Indomethacin 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 4.5 mg/ml
Trial: 8657434
Drug: Salicylic acid
RxNorm normalized name: Salicylic Acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salicylic acid (SA) 60 mg/ml
Trial: 2182235
Drug: Intravenous anistreplase
RxNorm normalized name: Anistreplase
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anistreplase (Eminase)
Trial: 2182235
Drug: Intravenous anistreplase
RxNorm normalized name: Anistreplase
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anistreplase (Eminase) and Intracoronary streptokinase
Trial: 114042
Drug: Low-lactose milk
RxNorm normalized name: CASEINATE/DEXTROSE/LACTOSE/MILK/MINERALS/MULTIVITAMINS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-lactose milk (500 ml twice daily for 1 month)
Trial: 25556539
Drug: Ropivacaine 0.75%,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.75%, 20 mL
Trial: 25556539
Drug: 0.9% saline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline, 20 mL
Trial: 24144222
Drug: Nebulised magnesium
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised magnesium sulphate (MgSO4) 151 mg
Trial: 1746414
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (placebo)
Trial: 3459390
Drug: Imipenem coadministered
RxNorm normalized name: Imipenem
DrugBank: Imipenem (DB01598)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Imipenem coadministered with cilastatin (1 g of imipenem and equal amounts of cilastatin)
Trial: 3459390
Drug: Moxalactam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxalactam (2 g)
Trial: 26244417
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) as an adjunct to Light Therapy (LT) for four weeks after two weeks of LT.
Trial: 26244417
Drug: No Treatment
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No Treatment (NT) after two weeks of Light Therapy (LT).
Trial: 22525670
Drug: Noninvasive cortical
RxNorm normalized name: Corticool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noninvasive cortical stimulation therapy
Trial: 10079411
Drug: St. John's
RxNorm normalized name: St. john's wort
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: St. John's wort (0.6 mg/mL)
Trial: 2184134
Drug: Thymopentin (TP-5)
RxNorm normalized name: thymopentin
DrugBank: Thymopentin (DB11996)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymopentin (TP-5) at 50 mg s.c. three times per week for one month
Trial: 28295825
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy (n=50), three sessions (once/week) including desensitization manoeuvres of the central nervous system
Trial: 11508581
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) in combination with low dose corticosteroids after 12 months of therapy
Trial: 7826827
Drug: Bendrofluazide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendrofluazide (10 mg)
Trial: 29308927
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose CRMRF
Trial: 29308927
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose CRMRF
Trial: 29308927
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose PSWT
Trial: 10596458
Drug: Usual dose
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual dose of insulin (0.1 U/kg)
Trial: 10596458
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of insulin (0.05 U/kg)
Trial: 1913493
Drug: DDP with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DDP with DSM (600 mg degradable starch microspheres)
Trial: 1913493
Drug: DDP alone
RxNorm normalized name: DDP-200
DrugBank: DDP-200 (DB05919)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DDP alone (25 mg/m2)
Trial: 31313548
Drug: Triple pill
RxNorm normalized name: Triple Wormer Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple pill of telmisartan/amlodipine/hydrochlorothiazide
Trial: 31313548
Drug: Dual combination
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual combination of telmisartan/hydrochlorothiazide
Trial: 24129543
Drug: Cognitive‐behavioral therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐behavioral therapy (Coping Cat)
Trial: 24129543
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cognitive‐behavioral therapy and medication
Trial: 17324657
Drug: Nutrition intervention
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition intervention (nutrition counseling following the ADA medical nutrition therapy protocol)
Trial: 15014864
Drug: Hypromellose and
RxNorm normalized name: Hypromellose and phenylephrine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypromellose and Lacri‐Lube combination (HL)
Trial: 9659017
Drug: morphine 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: morphine 0.15 mg.kg‐1
Trial: 8595681
Drug: Alkalinized lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alkalinized lidocaine 2% (1 ml NaHCO3 per 10 ml of solution) injected immediately
Trial: 8595681
Drug: Alkalinized lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alkalinized lidocaine 2% (1 ml NaHCO3 per 10 ml of solution) injected one hour after preparation
Trial: 2668006
Drug: Intravenous L-carnitine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous L-carnitine at a dose of 100 mg kg‐1 b.w. every 12 h for 36 h
Trial: 31187437
Drug: 300-mg single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300-mg single-dose tafenoquine
Trial: 28437278
Drug: Landiolol (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol (12 mg/mL formulation) administered via dose-escalation regimen (10 μg/kg BW/min for 2 hours, 20 μg/kg BW/min for 2 hours, 40 μg/kg BW/min for 20 hours, 6 hours follow-up)
Trial: 28437278
Drug: Landiolol (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol (12 mg/mL formulation)
Trial: 16818564
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose of folate (60 microg/kg per day)
Trial: 9390112
Drug: Montelukast 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 0.4 mg
Trial: 2862946
Drug: Temazepam (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam (40 mg)
Trial: 27127136
Drug: Acetium lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetium lozenge (slow-release L-Cysteine)
Trial: 25029426
Drug: Aldosterone infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aldosterone infusion (0.7 μg/kg/h for 12.5 h)
Trial: 18363032
Drug: Monascus purpureus
RxNorm normalized name: Monascus purpureus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monascus purpureus Went rice (600 mg twice per day for one month, then once daily)
Trial: 18363032
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antidyslipidemic therapy)
Trial: 15601270
Drug: Intravenous colloid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous colloid (n = 18)
Trial: 12381337
Drug: Orlistat given
RxNorm normalized name: Orlistat
DrugBank: Orlistat (DB01083)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orlistat given as a capsule with the meal
Trial: 11247198
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid containing multivitamin preparation (4 mg of folic acid, calcium, iron, zinc, vitamins A, B1, B2, B6, C, D, and nicotinamide)
Trial: 9105061
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of FP and SLM
Trial: 8456421
Drug: sulotroban (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulotroban (2 mg/min, 4 mg/min, 8 mg/min)
Trial: 3104991
Drug: Enprostil (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enprostil (70 micrograms oral dose)
Trial: 3104991
Drug: Enprostil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enprostil (10 micrograms/ml) in rats
Trial: 22471135
Drug: Ergotamine and
RxNorm normalized name: Belladonna alkaloid and ergotamine and phenobarbital only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ergotamine and Caffeine tablets (oral administration)
Trial: 20937992
Drug: Cisplatin 50
RxNorm normalized name: cisplatin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 50 mg/m² on day 1 and topotecan 0.75 mg/m² on days 1-5 followed by paclitaxel 175 mg/m² on day 1 and carboplatin (AUC = 5) on day 1 for four cycles, then four cycles of paclitaxel and carboplatin.
Trial: 18260172
Drug: IV ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ibandronate (2 mg every 2 months)